-
1
-
-
33845864487
-
Long term proton pump inhibitor therapy and risk of hip fractures
-
Yang Y.-X., Lewis J.D., Epstein S., Metz D.C. Long term proton pump inhibitor therapy and risk of hip fractures. JAMA 2006, 296(24):2947-2953.
-
(2006)
JAMA
, vol.296
, Issue.24
, pp. 2947-2953
-
-
Yang, Y.-X.1
Lewis, J.D.2
Epstein, S.3
Metz, D.C.4
-
2
-
-
77953880651
-
Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients
-
Corley D.A., Kubo A., Zhao W., Quesenberry C. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology 2010, 139(1):93-101.
-
(2010)
Gastroenterology
, vol.139
, Issue.1
, pp. 93-101
-
-
Corley, D.A.1
Kubo, A.2
Zhao, W.3
Quesenberry, C.4
-
3
-
-
33748105475
-
Proton pump inhibitors, histamine H2 receptor antagonists and other antacid medication and risk of fracture
-
Vestegaard P., Rejnmakr L., Mosekilde L. Proton pump inhibitors, histamine H2 receptor antagonists and other antacid medication and risk of fracture. Calcif Tissue Int 2006, 79:76-83.
-
(2006)
Calcif Tissue Int
, vol.79
, pp. 76-83
-
-
Vestegaard, P.1
Rejnmakr, L.2
Mosekilde, L.3
-
4
-
-
77952115101
-
Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women
-
Gray S.L., LaCroix A.Z., Larson J., Robbins J., Cauley J.A., Manson J.E., et al. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women. Arch Intern Med 2010, 170(9):765-771.
-
(2010)
Arch Intern Med
, vol.170
, Issue.9
, pp. 765-771
-
-
Gray, S.L.1
LaCroix, A.Z.2
Larson, J.3
Robbins, J.4
Cauley, J.A.5
Manson, J.E.6
-
5
-
-
54349103932
-
Acid-suppressive medication and risk of bone loss and fractures in older adults
-
Yu E.W., Blackwell T., Ensrud K.E., Hillier T.A., Lane L.E., Orwoll E., et al. Acid-suppressive medication and risk of bone loss and fractures in older adults. Calcif Tissue Int 2008, 83:251-259.
-
(2008)
Calcif Tissue Int
, vol.83
, pp. 251-259
-
-
Yu, E.W.1
Blackwell, T.2
Ensrud, K.E.3
Hillier, T.A.4
Lane, L.E.5
Orwoll, E.6
-
6
-
-
48249103083
-
Proton pump inhibitor use and risk of hip fractures in patients without major risk factors
-
Kaye J.A., Jick H. Proton pump inhibitor use and risk of hip fractures in patients without major risk factors. Pharmacotherapy 2008, 28(8):951-959.
-
(2008)
Pharmacotherapy
, vol.28
, Issue.8
, pp. 951-959
-
-
Kaye, J.A.1
Jick, H.2
-
7
-
-
58149279436
-
Increase in vertebral fracture risk in postmenopausal women using omeprazole
-
Roux C., Briot K., Gossec L., Kolta S., Blenk T., Felsenberg D., et al. Increase in vertebral fracture risk in postmenopausal women using omeprazole. Calcif Tissue Int 2009, 84:13-19.
-
(2009)
Calcif Tissue Int
, vol.84
, pp. 13-19
-
-
Roux, C.1
Briot, K.2
Gossec, L.3
Kolta, S.4
Blenk, T.5
Felsenberg, D.6
-
8
-
-
71849099123
-
Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphophonates
-
de Vries F., Cooper A.L., Cockle S.M., van Staa T.P., Cooper C. Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphophonates. Osteoporos Int 2009, 20(12):1989-1998.
-
(2009)
Osteoporos Int
, vol.20
, Issue.12
, pp. 1989-1998
-
-
de Vries, F.1
Cooper, A.L.2
Cockle, S.M.3
van Staa, T.P.4
Cooper, C.5
-
9
-
-
0030887253
-
Risk factors for hip fractures in men
-
Grisso J.A., Kelsey J.L., O'Brien L.A., Miles C.G., Sidney S., Maislin G., et al. Risk factors for hip fractures in men. Am J Epidemiol 1997, 145(9):786-793.
-
(1997)
Am J Epidemiol
, vol.145
, Issue.9
, pp. 786-793
-
-
Grisso, J.A.1
Kelsey, J.L.2
O'Brien, L.A.3
Miles, C.G.4
Sidney, S.5
Maislin, G.6
-
11
-
-
72149095440
-
Adverse risk associated with proton pump inhibitors: a systematic review
-
Heidelbaugh J.J., Goldberg K.L., Inadomi J.M. Adverse risk associated with proton pump inhibitors: a systematic review. Gastroenterol Hepatol 2009, 5(10):725-734.
-
(2009)
Gastroenterol Hepatol
, vol.5
, Issue.10
, pp. 725-734
-
-
Heidelbaugh, J.J.1
Goldberg, K.L.2
Inadomi, J.M.3
-
12
-
-
84890757019
-
Chapter 14: Adverse effects
-
John Wiley & Sons, Chichester (UK, J.P.T. Higgins, S. Green (Eds.)
-
Loke Y.K., Price D., Herxheimer A. Chapter 14: Adverse effects. Cochrane Handbook for Systematic Reviews of Interventions 2008, John Wiley & Sons, Chichester (UK. J.P.T. Higgins, S. Green (Eds.).
-
(2008)
Cochrane Handbook for Systematic Reviews of Interventions
-
-
Loke, Y.K.1
Price, D.2
Herxheimer, A.3
-
13
-
-
0032574489
-
When can odds ratios mislead?
-
Davies H.T., Crombie I.K., Tavakoli M. When can odds ratios mislead?. BMJ 1998, 316(7136):989-991.
-
(1998)
BMJ
, vol.316
, Issue.7136
, pp. 989-991
-
-
Davies, H.T.1
Crombie, I.K.2
Tavakoli, M.3
-
14
-
-
0041876133
-
Measuring inconsistency in meta-analyses
-
Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560.
-
(2003)
BMJ
, vol.327
, Issue.7414
, pp. 557-560
-
-
Higgins, J.P.1
Thompson, S.G.2
Deeks, J.J.3
Altman, D.G.4
-
15
-
-
0030793120
-
The results of direct and indirect treatment comparison in meta-analysis of randomized controlled trials
-
Bucher H.C., Guyatt G.H., Griffith L.E., Walter S.D. The results of direct and indirect treatment comparison in meta-analysis of randomized controlled trials. J Clin Epidemiol 1997, 50:683-691.
-
(1997)
J Clin Epidemiol
, vol.50
, pp. 683-691
-
-
Bucher, H.C.1
Guyatt, G.H.2
Griffith, L.E.3
Walter, S.D.4
-
16
-
-
70449503965
-
-
Canadian Agency for Drugs and Technologies in Health, Ottawa, Available at:, (accessed 3 February 2010)
-
Well G.A., Sultan S.A., Chen L., Khan M., Coyle D. Indirect treatment comparison [computer program] 1.0 edn 2010, Canadian Agency for Drugs and Technologies in Health, Ottawa, Available at:, (accessed 3 February 2010). http://www.cadth.ca/index.php/en/itc-user-guide.
-
(2010)
Indirect treatment comparison [computer program] 1.0 edn
-
-
Well, G.A.1
Sultan, S.A.2
Chen, L.3
Khan, M.4
Coyle, D.5
-
17
-
-
49749141653
-
Use of proton pump inhibitors and risk of osteoporosis-related fractures
-
Targownik L.E., Lix L.M., Metge C.J., Prior H.J., Leung S., Leslie W.D. Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ 2008, 179(4):319-326.
-
(2008)
CMAJ
, vol.179
, Issue.4
, pp. 319-326
-
-
Targownik, L.E.1
Lix, L.M.2
Metge, C.J.3
Prior, H.J.4
Leung, S.5
Leslie, W.D.6
-
18
-
-
79951681137
-
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
-
[Electronic publication ahead of print]
-
Pouwels S., Lalmohamed A., Souverein P., Cooper C., Veldt B.J., Leufkens, et al. Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study. Osteoporos Int Jun 29 2010, [Electronic publication ahead of print].
-
(2010)
Osteoporos Int
-
-
Pouwels, S.1
Lalmohamed, A.2
Souverein, P.3
Cooper, C.4
Veldt, B.J.5
Leufkens6
-
19
-
-
33748740823
-
-
Bonds D.E., Larson J.C., Schwartz A.V., Strotmeyer E.S., Robbins J., Rodriguez B.L., et al. J Clin Endocrinol Metab 2006, 91(9):3404-3410.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, Issue.9
, pp. 3404-3410
-
-
Bonds, D.E.1
Larson, J.C.2
Schwartz, A.V.3
Strotmeyer, E.S.4
Robbins, J.5
Rodriguez, B.L.6
-
20
-
-
21244436672
-
Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial
-
O'Connell M.B., Madden D.M., Murray A.M., Heaney R.P., Kerzner L.J. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med 2005, 118:778-781.
-
(2005)
Am J Med
, vol.118
, pp. 778-781
-
-
O'Connell, M.B.1
Madden, D.M.2
Murray, A.M.3
Heaney, R.P.4
Kerzner, L.J.5
-
21
-
-
0035996186
-
Calcium and phosphate plasma levels in dialysis patients after dietary Ca-P overload. Role of gastric acid secretion
-
Graziani G., Badalamenti S., Como G., Gallieni M., Finazzi S., Angelini C., et al. Calcium and phosphate plasma levels in dialysis patients after dietary Ca-P overload. Role of gastric acid secretion. Nephron 2002, 91:474-479.
-
(2002)
Nephron
, vol.91
, pp. 474-479
-
-
Graziani, G.1
Badalamenti, S.2
Como, G.3
Gallieni, M.4
Finazzi, S.5
Angelini, C.6
-
22
-
-
0029143723
-
Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects
-
Graziani G., Como G., Badalamentti S., Finazzi S., Malesci A., Gallieni M., et al. Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects. Nephrol Dial Transplant 1995, 10:1376-1380.
-
(1995)
Nephrol Dial Transplant
, vol.10
, pp. 1376-1380
-
-
Graziani, G.1
Como, G.2
Badalamentti, S.3
Finazzi, S.4
Malesci, A.5
Gallieni, M.6
-
23
-
-
0025778104
-
Calcium absorption in elderly subjects on high- and low-fiber diets: effect of gastric acidity
-
Knox T.A., Kassarjian Z., Dawson-Hughes B., Golner B.B., Dallal G.E., Arora S., et al. Calcium absorption in elderly subjects on high- and low-fiber diets: effect of gastric acidity. Am J Clin Nutr 1991, 53:1480-1486.
-
(1991)
Am J Clin Nutr
, vol.53
, pp. 1480-1486
-
-
Knox, T.A.1
Kassarjian, Z.2
Dawson-Hughes, B.3
Golner, B.B.4
Dallal, G.E.5
Arora, S.6
-
24
-
-
0021839201
-
Calcium absorption and achlorohydria
-
Recker R.R. Calcium absorption and achlorohydria. N Engl J Med 1985, 313:70-73.
-
(1985)
N Engl J Med
, vol.313
, pp. 70-73
-
-
Recker, R.R.1
-
25
-
-
0029156271
-
Hypochlorohydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans
-
Serfaty-Lacrosniere C., Wood R.J., Voytko D., Saltzman J.R., Pedrosa M., Sepe T.E., et al. Hypochlorohydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans. J Am Coll Nutr 1995, 14:364-368.
-
(1995)
J Am Coll Nutr
, vol.14
, pp. 364-368
-
-
Serfaty-Lacrosniere, C.1
Wood, R.J.2
Voytko, D.3
Saltzman, J.R.4
Pedrosa, M.5
Sepe, T.E.6
-
26
-
-
0023221104
-
Gastrointestinal absorption of calcium from milk and calcium salts
-
Sheikh M.S., Santa Ana C.A., Nicar M.J., Schiller L.F., Fordtran J.S. Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med 1987, 317:532-536.
-
(1987)
N Engl J Med
, vol.317
, pp. 532-536
-
-
Sheikh, M.S.1
Santa Ana, C.A.2
Nicar, M.J.3
Schiller, L.F.4
Fordtran, J.S.5
-
27
-
-
55449121118
-
Proton pump inhibitor therapy and osteoporosis
-
Yang Y.X. Proton pump inhibitor therapy and osteoporosis. Curr Drug Saf 2008, 2:204-209.
-
(2008)
Curr Drug Saf
, vol.2
, pp. 204-209
-
-
Yang, Y.X.1
-
28
-
-
0030852705
-
Chicken parathyroid hormone gene expression in response to gastrin, omeprazole, ergocalciferol and restricted food intake
-
Gagnemo-Persson R., Samuelsson A., Hakanson R., Persson P. Chicken parathyroid hormone gene expression in response to gastrin, omeprazole, ergocalciferol and restricted food intake. Calcif Tissue Int 1997, 61(3):210-215.
-
(1997)
Calcif Tissue Int
, vol.61
, Issue.3
, pp. 210-215
-
-
Gagnemo-Persson, R.1
Samuelsson, A.2
Hakanson, R.3
Persson, P.4
-
29
-
-
0017650992
-
The parathyroid glands in experimentally induced hypergastinemia in the rat
-
Grimelius L., Johnsson H., Lundqvist G., Olazabal A., Polak J.H., Pearse G.E. The parathyroid glands in experimentally induced hypergastinemia in the rat. Scand J Gastroenterol 1977, 12:739-744.
-
(1977)
Scand J Gastroenterol
, vol.12
, pp. 739-744
-
-
Grimelius, L.1
Johnsson, H.2
Lundqvist, G.3
Olazabal, A.4
Polak, J.H.5
Pearse, G.E.6
-
30
-
-
0036367733
-
Selective inhibition of osteoclast vacuolar H+ATPase
-
Farina C., Gagliardi S. Selective inhibition of osteoclast vacuolar H+ATPase. Curr Pharm Des 2002, 8:2033-2048.
-
(2002)
Curr Pharm Des
, vol.8
, pp. 2033-2048
-
-
Farina, C.1
Gagliardi, S.2
-
31
-
-
0141890294
-
Specific biological function of vacuolar-type H(+)-ATPase and lysosomal cysteine proteinase, cathepsin K, in osteoclasts
-
Sahara T., Itoh K., Debari K., Saski T. Specific biological function of vacuolar-type H(+)-ATPase and lysosomal cysteine proteinase, cathepsin K, in osteoclasts. Anat Rec Discov Mol Evol Biol 2003, 270(2):152-161.
-
(2003)
Anat Rec Discov Mol Evol Biol
, vol.270
, Issue.2
, pp. 152-161
-
-
Sahara, T.1
Itoh, K.2
Debari, K.3
Saski, T.4
-
32
-
-
9044253326
-
Recent advances in the ultrastructural assessment of osteoclastic resorptive functions
-
Saski T. Recent advances in the ultrastructural assessment of osteoclastic resorptive functions. Microsc Res Tech 1996, 33:182-191.
-
(1996)
Microsc Res Tech
, vol.33
, pp. 182-191
-
-
Saski, T.1
-
33
-
-
0034261467
-
Mechanism of proton transport in isolated rat osteoclasts attached to bone
-
Shibata T., Amano H., Yamada S., Ohya K. Mechanism of proton transport in isolated rat osteoclasts attached to bone. J Med Dent Sci 2000, 47(3):177-185.
-
(2000)
J Med Dent Sci
, vol.47
, Issue.3
, pp. 177-185
-
-
Shibata, T.1
Amano, H.2
Yamada, S.3
Ohya, K.4
-
34
-
-
0025869491
-
Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases
-
Mattsson J.P., Vaananen K., Wallmark B., Lorentzon P. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases. Biochim Biophys Acta 1991, 1065:261-268.
-
(1991)
Biochim Biophys Acta
, vol.1065
, pp. 261-268
-
-
Mattsson, J.P.1
Vaananen, K.2
Wallmark, B.3
Lorentzon, P.4
-
35
-
-
0027207229
-
Effect of omeprazole, an inhibitor of H+, K(+)-ATPase, on bone resorption in humans
-
Mizunashi K., Furukawa Y., Katano K., Abe K. Effect of omeprazole, an inhibitor of H+, K(+)-ATPase, on bone resorption in humans. Calcif Tissue Int 1993, 53:21-25.
-
(1993)
Calcif Tissue Int
, vol.53
, pp. 21-25
-
-
Mizunashi, K.1
Furukawa, Y.2
Katano, K.3
Abe, K.4
-
36
-
-
0033819342
-
Mineral density and bone strength are dissociated in long bones of rat osteopetrotic mutations
-
Tuukkanen J., Koivukangas A., Jamasa T., Sundquist K., Mackay C.A., Marks S.C. Mineral density and bone strength are dissociated in long bones of rat osteopetrotic mutations. J Bone Miner Res 2000, 15:1905-1911.
-
(2000)
J Bone Miner Res
, vol.15
, pp. 1905-1911
-
-
Tuukkanen, J.1
Koivukangas, A.2
Jamasa, T.3
Sundquist, K.4
Mackay, C.A.5
Marks, S.C.6
-
37
-
-
0344193122
-
Gastric fundectomy in the rat: effects on mineral and bone metabolism, with emphasis on the gastric-calcitonin-parathyroid hormone-vitamin D axis
-
Rumenapf G., Schwille P.O., Erben R.G., Schreiber M., Berge B., Fries W., et al. Gastric fundectomy in the rat: effects on mineral and bone metabolism, with emphasis on the gastric-calcitonin-parathyroid hormone-vitamin D axis. Calcif Tissue Int 1998, 63(5):433-441.
-
(1998)
Calcif Tissue Int
, vol.63
, Issue.5
, pp. 433-441
-
-
Rumenapf, G.1
Schwille, P.O.2
Erben, R.G.3
Schreiber, M.4
Berge, B.5
Fries, W.6
-
38
-
-
0034532921
-
Vagus-sparing gastric fundectomy in the rat: development of osteopenia, relationship to urinary phosphate and net acid excretion, serum gastric and vitamin D
-
Gepp H., Koch M., Scwille P.O., Erben R.G., Rumeaphf G., Schmiedl A., et al. Vagus-sparing gastric fundectomy in the rat: development of osteopenia, relationship to urinary phosphate and net acid excretion, serum gastric and vitamin D. Res Exp Med (Berl) 2000, 200:1-16.
-
(2000)
Res Exp Med (Berl)
, vol.200
, pp. 1-16
-
-
Gepp, H.1
Koch, M.2
Scwille, P.O.3
Erben, R.G.4
Rumeaphf, G.5
Schmiedl, A.6
-
39
-
-
77249135057
-
Proton-pump inhibitors use is not associated with osteoporosis or accelerated bone mineral density loss
-
Targownik L.E., Lix L.M., Leung S., Leslie W.D. Proton-pump inhibitors use is not associated with osteoporosis or accelerated bone mineral density loss. Gastroenterology 2010, 138:896-904.
-
(2010)
Gastroenterology
, vol.138
, pp. 896-904
-
-
Targownik, L.E.1
Lix, L.M.2
Leung, S.3
Leslie, W.D.4
-
40
-
-
34247523621
-
The appropriateness of asymmetry test for publication bias in meta-analyses: a large survey
-
Ioannidis J.P., Trikalinos T.A. The appropriateness of asymmetry test for publication bias in meta-analyses: a large survey. CMAJ 2007, 176:1091-1096.
-
(2007)
CMAJ
, vol.176
, pp. 1091-1096
-
-
Ioannidis, J.P.1
Trikalinos, T.A.2
|